直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Dismisses Appeal Regarding Real Parties in Interest for Lack of Standing

July 17, 2025

Authored and Edited by Ryan V. McDonnell; Erik R. Puknys; *Erin Lynch

In Dolby Laboratories Licensing Corporation v. Unified Patents, LLC, No. 2023-2110 (Fed. Cir. June 5, 2025), the Federal Circuit dismissed Dolby’s appeal of a final written decision of the Patent Trial and Appeal Board for lack of Article III standing, determining that Dolby had not established a sufficient injury in fact. Before the Board, Dolby argued that nine other entities should have been named as real parties in interest (RPIs) after the Board instituted review with Unified Patents as the sole RPI. In the appeal, Dolby challenged the Board’s refusal to adjudicate the RPI dispute. Unified Patents and the Patent Office, as intervenor, challenged Dolby’s standing to appeal.

Dolby argued that it had standing for three reasons: (1) it was a “dissatisfied” party having a statutory right to appeal under 35 U.S.C. § 319; (2) it was harmed by the violation of its informational right to know all RPIs in IPR proceedings under 35 U.S.C. § 312(a)(2); and (3) it was harmed in various ways from the Board’s refusal to adjudicate the RPI dispute.

The Federal Circuit rejected each of Dolby’s theories. The court stated that the statutory right of a dissatisfied party to appeal a decision under the AIA does not eliminate the injury-in-fact requirement for Article III standing. The court also clarified that there is no freestanding right to RPI information outside of IPR proceedings and emphasized that Dolby’s alleged harms were too speculative to establish Article III standing because there was no evidence of conflicts of interest, license agreements, or threatened litigation.

Tags

Patent Trial and Appeal Board (PTAB), standing

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Communications

Media

Related Offices

Palo Alto, CA

Washington, DC

Contacts

Ryan V. McDonnell
Associate
Washington, DC
+1 202 408 4167
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

*Erin Lynch is a Summer Associate at Finnegan. 

Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Seminar

Future IP UK

October 21, 2026

London

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Seminar

IAM and WTR Live: Australasia IP Forum 2026

August 11, 2026

Melbourne

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP